Cargando…

Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner

Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype independent of estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. It has a poor prognosis and high recurrence. Due to its limited treatment options in the clinic, novel therapies are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xinyu, Soto-Gamez, Abel, Nijdam, Fleur, Setroikromo, Rita, Quax, Wim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762273/ https://www.ncbi.nlm.nih.gov/pubmed/35047402 http://dx.doi.org/10.3389/fonc.2021.789336

Ejemplares similares

Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53
por: Zhou, Xinyu, et al.
Publicado: (2020)

Therapeutic effects of dihydroartemisinin and transferrin against glioblastoma
por: Kim, Suk Hee, et al.
Publicado: (2016)

Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
por: Zhang, Baojie, et al.
Publicado: (2019)

Death Receptor 5 Displayed on Extracellular Vesicles Decreases TRAIL Sensitivity of Colon Cancer Cells
por: Setroikromo, Rita, et al.
Publicado: (2020)

Receptor Specificity Engineering of TNF Superfamily Ligands
por: Suo, Fengzhi, et al.
Publicado: (2022)

Erratum to: the ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
por: van Roosmalen, Ingrid AM, et al.
Publicado: (2014)

The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
por: van Roosmalen, Ingrid A M, et al.
Publicado: (2014)

Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
por: Kong, Rui, et al.
Publicado: (2012)

Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1
por: Ba, Qian, et al.
Publicado: (2012)

Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol–dihydroartemisinin conjugate
por: Liu, Kefeng, et al.
Publicado: (2016)

Correction: Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
por: Kong, Rui, et al.
Publicado: (2012)

Production of α-cuprenene in Xanthophyllomyces dendrorhous: a step closer to a potent terpene biofactory
por: Melillo, Elena, et al.
Publicado: (2013)

Immobilized Acylase PvdQ Reduces Pseudomonas aeruginosa Biofilm Formation on PDMS Silicone
por: Vogel, Jan, et al.
Publicado: (2020)

Improving TRAIL-induced apoptosis in cancers by interfering with histone modifications
por: Zhang, Bao-Jie, et al.
Publicado: (2020)

PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection
por: Utari, Putri D., et al.
Publicado: (2018)

Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants
por: Reis, C R, et al.
Publicado: (2010)

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013)

Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer
por: Gao, Song, et al.
Publicado: (2015)

A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
por: Soto-Gamez, Abel, et al.
Publicado: (2020)

Development and application of CRISPR‐based genetic tools in Bacillus species and Bacillus phages
por: Song, Yafeng, et al.
Publicado: (2022)

Transferrin Ensures Survival of Ovarian Carcinoma Cells Subjected to Deferoxamine, TNFA, FASL, Trail or MYC-Activation
por: Rosenberger, Georg, et al.
Publicado: (2001)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

Death receptor 5 is activated by fucosylation in colon cancer cells
por: Zhang, Baojie, et al.
Publicado: (2019)

Creation of RANKL mutants with low affinity for decoy receptor OPG and their potential anti‐fibrosis activity
por: Wang, Yizhou, et al.
Publicado: (2019)

Attenuation of autophagy flux by 6-shogaol sensitizes human liver cancer cells to TRAIL-induced apoptosis via p53 and ROS
por: Nazim, Uddin MD., et al.
Publicado: (2019)

Metabolic engineering of Bacillus subtilis for terpenoid production
por: Guan, Zheng, et al.
Publicado: (2015)

Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma
por: Shen, Ying, et al.
Publicado: (2020)

Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis
por: Koppensteiner, Herwig, et al.
Publicado: (2014)

ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation
por: Park, Eunhee, et al.
Publicado: (2019)

Production of Squalene in Bacillus subtilis by Squalene Synthase Screening and Metabolic Engineering
por: Song, Yafeng, et al.
Publicado: (2020)

Rapid endocytosis of the transferrin receptor in the absence of bound transferrin
Publicado: (1985)

The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010)

Protein adduction causes non-mutational inhibition of p53 tumor suppressor
por: Gokulan, Ravindran Caspa, et al.
Publicado: (2023)

Pilot study: bioequivalence of dihydroartemisinin in dihydroartemisinin-piperaquine tablet generic formulation in healthy Indonesian volunteers
por: Isnawati, Ani, et al.
Publicado: (2023)

Dihydroartemisinin attenuates lipopolysaccharide-induced acute lung injury in mice by suppressing NF-κB signaling in an Nrf2-dependent manner
por: Huang, Xiao-Ting, et al.
Publicado: (2019)

Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner
por: Chen, Minghui, et al.
Publicado: (2016)

Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity
por: Wang, Zeng, et al.
Publicado: (2012)

H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner
por: Sakamoto, Soichiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nj54tfg5hr12p53mthl6h421a2